Literature DB >> 25608923

Presepsin: solving a soluble (CD14) problem in sepsis?

Gareth L Ackland1, John R Prowle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25608923     DOI： 10.1007/s00134-014-3642-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  20 in total

Review 1.  Time to abandon dogma: CD14 is expressed by non-myeloid lineage cells.

Authors:  Hubertus P A Jersmann
Journal:  Immunol Cell Biol       Date:  2005-10       Impact factor: 5.126

Review 2.  How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease.

Authors:  V O Puntmann
Journal:  Postgrad Med J       Date:  2009-10       Impact factor: 2.401

3.  Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial.

Authors:  Serge Masson; Pietro Caironi; Caterina Fanizza; Ralf Thomae; Roberto Bernasconi; Andrea Noto; Roberto Oggioni; Giovanni Stefano Pasetti; Marilena Romero; Gianni Tognoni; Roberto Latini; Luciano Gattinoni
Journal:  Intensive Care Med       Date:  2014-10-16       Impact factor: 17.440

Review 4.  CD14++ monocytes, CD14+/CD16+ subset and soluble CD14 as biological markers of inflammatory systemic diseases and monitoring immunosuppressive therapy.

Authors:  J E Scherberich; W A Nockher
Journal:  Clin Chem Lab Med       Date:  1999-03       Impact factor: 3.694

5.  Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population.

Authors:  Oh Joo Kweon; Jee-Hye Choi; Sang Kil Park; Ae Ja Park
Journal:  J Crit Care       Date:  2014-06-21       Impact factor: 3.425

6.  Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock.

Authors:  Caroline Landelle; Alain Lepape; Nicolas Voirin; Eve Tognet; Fabienne Venet; Julien Bohé; Philippe Vanhems; Guillaume Monneret
Journal:  Intensive Care Med       Date:  2010-07-23       Impact factor: 17.440

7.  Role of Presepsin (sCD14-ST) and the CURB65 scoring system in predicting severity and outcome of community-acquired pneumonia in an emergency department.

Authors:  Bo Liu; Qin Yin; Yun-Xia Chen; Yun-Zhou Zhao; Chun-Sheng Li
Journal:  Respir Med       Date:  2014-06-02       Impact factor: 3.415

8.  Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14.

Authors:  M O Labeta; J J Durieux; N Fernandez; R Herrmann; P Ferrara
Journal:  Eur J Immunol       Date:  1993-09       Impact factor: 5.532

Review 9.  Net reclassification indices for evaluating risk prediction instruments: a critical review.

Authors:  Kathleen F Kerr; Zheyu Wang; Holly Janes; Robyn L McClelland; Bruce M Psaty; Margaret S Pepe
Journal:  Epidemiology       Date:  2014-01       Impact factor: 4.822

10.  Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment.

Authors:  Michael Behnes; Thomas Bertsch; Dominic Lepiorz; Siegfried Lang; Frederik Trinkmann; Martina Brueckmann; Martin Borggrefe; Ursula Hoffmann
Journal:  Crit Care       Date:  2014-09-05       Impact factor: 9.097
View more
  4 in total

1.  Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates.

Authors:  Lorenza Pugni; Carlo Pietrasanta; Silvano Milani; Claudia Vener; Andrea Ronchi; Mariella Falbo; Milena Arghittu; Fabio Mosca
Journal:  PLoS One       Date:  2015-12-31       Impact factor: 3.240

2.  Head-to-head comparison of procalcitonin and presepsin for the diagnosis of sepsis in critically ill adult patients: a protocol for a systematic review and meta-analysis.

Authors:  Kei Hayashida; Yutaka Kondo; Yoshitaka Hara; Morio Aihara; Kazuma Yamakawa
Journal:  BMJ Open       Date:  2017-03-06       Impact factor: 2.692

3.  Cerebrospinal Fluid Presepsin As a Marker of Nosocomial Infections of the Central Nervous System: A Prospective Observational Study.

Authors:  Sergey A Abudeev; Kirill V Kiselev; Nikolay M Kruglyakov; Ksenia A Belousova; Inna N Lobanova; Oleg V Parinov; Yuriy D Udalov; Maxim A Zabelin; Alexandr S Samoilov; Evaldas Cesnulis; Tim Killeen; Konstantin A Popugaev
Journal:  Front Neurol       Date:  2018-02-15       Impact factor: 4.003

4.  Dynamic blood presepsin levels are associated with severity and outcome of acute pancreatitis: A prospective cohort study.

Authors:  Hong-Li Xiao; Guo-Xing Wang; Yan Wang; Zhi-Min Tan; Jie Zhou; Han Yu; Miao-Rong Xie; Chun-Sheng Li
Journal:  World J Gastroenterol       Date:  2022-09-21       Impact factor: 5.374
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.